Urinary Bladder, Overactive Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Urinary Bladder, Overactive clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Ambulatory Long Length URodynamics Evaluation

Benign Prostatic HyperplasiaUrodynamicsUrinary Bladder, Overactive+4 more
Bright Uro101 enrolled7 locationsNCT07425015
Recruiting
Not Applicable

Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder

Urinary Bladder, Overactive
Pamukkale University63 enrolled1 locationNCT07366918
Recruiting
Phase 4

Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

Effect of DrugUrinary Bladder, Overactive
Mackay Memorial Hospital300 enrolled1 locationNCT06479720
Recruiting
Phase 4

Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity

Effect of DrugUrodynamicsUrinary Bladder, Overactive
Mackay Memorial Hospital300 enrolled1 locationNCT05968885
Recruiting
Phase 4

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

Effect of DrugUrinary Bladder, Overactive
Mackay Memorial Hospital200 enrolled1 locationNCT06197295
Recruiting

Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women

Urinary IncontinenceUrinary Incontinence, StressUrinary Bladder, Overactive+3 more
Szeged University80 enrolled1 locationNCT06933407
Recruiting

NXT Post-Market Clinical Follow-up

Urinary IncontinenceUrinary Bladder, NeurogenicUrinary Bladder, Overactive+2 more
Laborie Medical Technologies Inc.180 enrolled4 locationsNCT06336304
Recruiting
Phase 4

Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

NocturiaUrinary Urge IncontinenceIncontinence, Urinary+3 more
University of South Florida60 enrolled2 locationsNCT04305743